Proteomic Assessment of iTRAQ-Based NaoMaiTong in the Treatment of Ischemic Stroke in Rats

<table class="fixed-width table-group" id="tab5"><tr><td><table class="table"><colgroup><col style="width:14.14em"/><col style="width:3.83em"/><col style="width:4.86em"/><col style="width:4.91em"/><col style="width:12.11em"/></colgroup><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">Pathway</td><td class="align_center">Count</td><td class="align_center">p-Value</td><td class="align_center">q-Value</td><td class="align_center">Gene</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">Ribosome</td><td class="align_center">4</td><td class="align_center">1.72E-08</td><td class="align_center">3.44E-08</td><td class="align_center">RPl26; RPS13; RPl17; RPl39</td></tr><tr><td class="align_left">Tight junction</td><td class="align_center">3</td><td class="align_center">3.36E-04</td><td class="align_center">2.24E-04</td><td class="align_center">Tuba; Rac1; NWASP</td></tr><tr><td class="align_left">Regulation of actin cytoskeleton</td><td class="align_center">2</td><td class="align_center">2.67E-03</td><td class="align_center">8.90E-04</td><td class="align_center">Rac1; NWASP</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Evidence-Based Complementary and Alternative Medicine

tab5

Table 5

Table 5: Proteomic Assessment of iTRAQ-Based NaoMaiTong in the Treatment of Ischemic Stroke in Rats 